This award recognizes Clario s commitment to delivering the levels of excellence and innovation required to ensure data integrity in clinical trials. Clario.
/PRNewswire/ Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a.
Clario s Precision Motion Opal® wearable sensor technology detects early Parkinson s disease (PD) progression in a University of Oxford study funded by UCB.
Elevating Clinical Trial Quality and Accelerating Approval: Clario s Expertise Enables Breakthrough Alzheimer s Treatment Complicated clinical trials need to.